Blue Horseshoe Stocks: Bottom-Plays, Updates & More


BioNovelus, Inc. ONOV

For the third day in a row we’re bringing our readers up to speed on new highs for ONOV, a stock we’ve been tracking since  April from a low of .006, which has been continuing to break out like crazy this week.

We said in was in blue-sky territory in yesterday morning’s premarket report, and it did indeed continue to soar into the atmosphere. From an early low-of-day at .11 it got a boost all the way up to its new high of .15. It went down in the books as a 36% intraday pop, and a megalithic move of 2400% over our witnessed low from earlier this spring!

Cheers go out to any of our readers who were able to carve out a slice of the ONOV pie, it’s been quite a ride thus far!


Bottom-Play Possibilities:

As most of our audience is surely aware by now, we love a good bottom-bounceplay opportunity, and in the past, catching stocks that have taken recent beating at just the right moment has served us quite well. We’ve got a couple of potentials in that arena this morning that we’ll want to have an eye on over the next few sessions.

Infinity Pharmaceuticals, Inc. INFI – This is a classic case of negative hype and unfavorable news simultaneously converging to form a perfect storm of stock bashing. Just look at the massive gap on the chart, even a partial re-filling of which would produce sizable gain opportunities. The enormous selloff which occurred led to new lows, but INFI gave something of a bounce signal during yesterday’s session, so we’ll be quite interested to see how the activity unfolds from this juncture.

FXCM, Inc. FXCM – Also giving off a strong bottom signal is FXCM, a stock we rode to multi-bag gains back in December. We want to come back and give some attention to this play as it has come down to find support near its 6-month lows, and appears ready for a possible rebound. We’ll want to be watching for when that occurs.


Extended Watchlist:
CRDS, MUX, AG, NUGT, GDX, AEGR(Bottom-Watch)

Blue Horseshoe Stocks: Final Report of 2014

Good Morning Traders! Here it is- the final report of 2014! We had an amazing year, with huge gainers popping out of the woodwork left, right, and center! We want to take this opportunity to thank all of our readers for being a part of our community, wish you all a Happy New Year while reminding everyone that the best is yet to come… Each year our resolution remains the same: To make the upcoming year our best one ever! We’ve succeeded time and time again, and have no reason to believe that 2015 will be any different so be sure to stay with us! Cheers!


NeuroDerm Ltd. NDRM
NDRM exceeded all expectations yesterday after we caught it on an early morning news scan; it spent the entire day in full-on breakout mode setting records in both price and volume, trading almost 27X the norm over the six week period since the stock’s IPO.

Positive response to yesterday’s early morning press statement hurtled NDRM from an early low of 8.16 all the way up to 19.07 just prior to the close, making gains of up to 134% possible.

We’ll still be standing at the ready for an eventual course correction and chance for a dip-and-rip maneuver, but any way you slice it, NDRM is getting marked down as a huge winner. It’s a great way to close out what has, on the whole, been an absolutely stellar year.

NeuroDerm Announces Topline Results of Phase IIa Pharmacokinetic Study of ND0612H and ND0612L, Continuous, Subcutaneously Delivered Levodopa/Carbidopa for the Treatment of Parkinson’s Disease (Tue 7:00AM EST)


Precious Metals on Watch: Gold, Silver

GDX and SLV have each been maintaining higher highs and higher lows since reaching a bottom in November. As we head into the New Year, we’re going to devote a good amount of focus to gold and silver, and tracking these indices and their options chains is going to be a good way to do that.

In particular, we’re going to be monitoring a few specific sets of contracts for each play:

  SLV – March $15-15.50 Calls

GDX – March $17.50-$18 Calls

As you can see from the side-by-side chart we drew up below, GDX and SLV are looking similarly ripe. We’ve got SLV breaking the 50-Line on the RSI, and GDX following closely behind in that regard, we’re seeing testing of the 50DMA’s on both charts, and each of the MACD’s are giving the indication of bullish crosses.


Side Note:
We’re also going to radar HMCP, a sub-penny momentum play that has had an interesting past few sessions.


Extended Watchlist:
NRX, RDHL, MIG, CYTK, NEON, BCLI, CVEO

Get Our FREE Daily Reports!